Business Context and Reporting Period
This Form 6-K filing by Icecure Medical Ltd. covers the month of April 2026, with a report date of April 22, 2026. The filing serves to distribute materials for a Special General Meeting of Shareholders scheduled for May 11, 2026. The Company is a Foreign Private Issuer based in Caesarea, Israel, and files annual reports under Form 20-F.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document is a procedural filing regarding shareholder meeting logistics and does not contain financial statements or performance data.
Material Changes
No material changes to financial performance or operations are reported in this filing. The primary event is the convening of a Special General Meeting for shareholders of record as of April 27, 2026.
Guidance, Outlook, and Risks
The filing incorporates by reference the Notice of Meeting, Proxy Statement, and Proxy Card (Exhibits 99.1, 99.2, and 99.3) but does not explicitly detail management guidance, future outlook, specific risks, or contingencies within the cover text. The document notes that this report is incorporated into the Company's Registration Statements on Form F-3 and Form S-8.
Key Facts for Investor Verification
- Special General Meeting of Shareholders is scheduled for May 11, 2026.
- Record date for voting eligibility is April 27, 2026.
- Shareholders must review the attached Proxy Statement (Exhibit 99.2) for specific agenda items and voting instructions.
- This filing updates the Company's active registration statements (Form F-3 and Form S-8) by reference.
- No financial performance data is included in this specific filing.